Biodegradable Metal-Based Stents: Advances, Challenges, and Prospects

TL;DR

This review provides a comprehensive overview of biodegradable metal-based vascular stents, highlighting their potential to overcome the limitations of traditional stents. It delves into the material science, design principles, and in vitro/in vivo evaluation methods for magnesium, iron, and zinc alloys, while also discussing current challenges and future prospects for this promising medical technology.

What Problem Does This Paper Address?

Cardiovascular disease remains a leading cause of mortality worldwide, with coronary artery disease being a major contributor. Percutaneous coronary intervention (PCI) using stents is a common treatment to restore blood flow in narrowed arteries. However, traditional bare-metal stents (BMSs) and drug-eluting stents (DESs) have drawbacks. BMSs can lead to restenosis and thrombosis, while DESs, despite reducing restenosis, still involve permanent implants that can cause long-term complications like inflammation and late-stage thrombosis. The paper addresses the need for a stent that provides temporary mechanical support and then safely degrades and is absorbed by the body, thus eliminating the risks associated with permanent implants. Biodegradable metallic vascular stents are presented as a promising solution due to their potential for superior mechanical properties, excellent biocompatibility, and controlled degradation.

Methods

The paper discusses a range of methods used to evaluate biodegradable metal-based stents, broadly categorized into:

• Material Characterization: This includes assessing mechanical properties (yield strength, tensile strength, elongation, hardness), chemical characteristics (biodegradability, ion release), and microstructural features (grain size).
• In Vitro Corrosion Testing: This involves simulating physiological conditions to study stent degradation. Key techniques discussed include:
• Immersion Tests: Placing stents in simulated body fluids (SBFs) like Hank's, SBF, m-SBF, PBS, etc., to monitor corrosion rates and byproducts.
• Dynamic Immersion Tests: Simulating hemodynamic conditions (blood flow, shear stress) using bioreactors to better mimic the in vivo environment.
• Electrochemical Polarization Curves: Used to analyze corrosion behavior and kinetics.
• Parameter Control: Emphasizing the importance of controlling pH, dissolved oxygen concentration, and temperature in simulated body fluids for accurate results.
• Biocompatibility Testing:
  • Hemocompatibility: Assessing interactions with blood, including hemolysis ratio (assessing red blood cell rupture) and platelet adhesion.
• Cytotoxicity Testing: Evaluating the toxicity of materials and their degradation products on various cell lines (e.g., endothelial cells, smooth muscle cells) using methods like MTT and WST-1 assays.
• In Vivo Studies:
  • Animal Experiments: Preliminary assessment of stent feasibility, safety, degradation characteristics, and mechanical property changes in animal models.
• Clinical Trials: Evaluating the safety and efficacy of stents in human patients, focusing on outcomes like restenosis, thrombosis, and target lesion failure.
• Stent Structure Design and Optimization: Investigating different stent designs (e.g., link stents, RVE/RUC structures) and using computational methods like Finite Element Analysis (FEA) to optimize mechanical properties, drug release, and degradation.

Datasets

Not explicitly discussed in the paper in terms of training or evaluation datasets for machine learning models. The paper relies on experimental data from various studies and clinical trials.

Key Insights and Ideas

• The "Third Generation" of Stents: Biodegradable metal-based stents represent a significant advancement beyond traditional BMS and DES, aiming to eliminate the long-term risks associated with permanent implants.
• Material Trade-offs are Crucial: Each of the primary biodegradable metals (Mg, Fe, Zn) has distinct advantages and disadvantages regarding degradation rate, mechanical strength, and biocompatibility, necessitating careful alloy design and structural optimization.
• In Vitro Simulation Needs Sophistication: Accurately mimicking the complex and dynamic in vivo environment in vitro is challenging but critical for reliable degradation and biocompatibility assessments. Factors like hemodynamic parameters, pH, DO, and temperature play vital roles.
• Structure Dictates Performance: Beyond material composition, the stent's structural design (e.g., link types, cell geometry, micro-tanks) significantly influences its mechanical properties, drug delivery, and degradation behavior.
• Personalized Stents are the Future: The development of patient-specific stents, guided by advanced imaging and CAD technologies, holds promise for improved fit, reduced complications, and tailored treatment.

Key Results

• Mg Alloys: Offer excellent biocompatibility but suffer from rapid degradation and potential hydrogen gas release. Surface modifications and novel alloy compositions are being explored to control degradation.
• Fe Alloys: Provide good mechanical properties and biocompatibility with a slow degradation rate, but this can lead to late thrombosis and interference with MRI. Research focuses on enhancing degradation rates and understanding corrosion product metabolism.
• Zn Alloys: Exhibit a moderate degradation rate, falling between Mg and Fe, and good biocompatibility. Their mechanical properties are generally inferior, but alloying shows promise for improvement.
• Clinical Trial Successes: Several magnesium-based stents (e.g., DREAMS series) have shown promising safety and efficacy in clinical trials, with good lumen gain and low rates of restenosis and thrombosis, though some still face challenges with degradation speed and stent shape maintenance.
• Iron-based stents have demonstrated good biocompatibility in animal studies, with some showing slower degradation than magnesium.
• Zinc-based alloys show potential, with pure Zn exhibiting good biocompatibility and a suitable degradation rate, though mechanical properties remain a concern.

Limitations and Future Work

• In Vitro vs. In Vivo Discrepancies: The paper acknowledges that in vitro experiments cannot fully replicate the complex physiological conditions, leading to discrepancies in corrosion behavior. Future work should focus on developing more accurate simulation environments that account for temporal changes.
• Cytotoxicity Assessment Gaps: Current cytotoxicity studies often focus on extracts and soluble ions, potentially overlooking the toxicity of insoluble degradation products. There's a need for comprehensive assessments and the use of disease-specific cell models to better replicate clinical scenarios.
• Long-Term Data Needs: While progress has been made, the long-term degradation behavior and physiological effects of magnesium and iron stents, as well as the metabolic pathways of their corrosion products, remain poorly understood.
• Stent Structure Optimization: Further research is needed to optimize stent structures that balance multiple performance metrics (e.g., radial stiffness, flexibility, drug release) and perfectly fit diverse vascular geometries.
• Personalized Stent Fabrication: While 3D printing shows promise for personalized stents, its application to metal-based stents is still under exploration.
• Alloying Challenges: For zinc alloys, enhancing mechanical properties through alloying needs careful consideration of potential impacts on biocompatibility due to new phases and corrosion products.
• Standardization: The paper highlights the significant variability in experimental conditions for biocompatibility studies, emphasizing the need for standardized test conditions and evaluation criteria to improve comparability across research.